Christopher Simms has served as 4DMT's Chief Commercial and Business Officer since December 2025, and served as Chief Commercial Officer from September 2024 until December 2025.
Mr. Simms previously served as Chief Commercial Officer at IVERIC bio, Inc. from August 2021 to July 2024. From November 2017 to July 2021, he served in various roles at Novartis AG, most recently as VP, Head of US Ophthalmics.
Mr. Simms holds an MBA degree from York University, Schulich School of Business, and a Bachelor of Commerce from Memorial University of Newfoundland.